Amaç: Pozitron emisyon tomografisi/bilgisayarlı tomografi (PET/BT) görüntülemesinde kolorektal bölgede görülen rastlantısal fokal 18-florodeoksiglukoz (18F-FDG) tutulumu, adenomlar gibi premalign lezyonları veya maligniteleri işaret edebilir. Erken teşhis ve tanı, kanserin önlenmesi açısından hayati öneme sahiptir. Bu çalışmanın amacı, benign, premalign ve malign lezyonlarla ilişkili rastlantısal fokal kolonik FDG tutulumunun özelliklerini değerlendirmek ve kolonoskopi gerekliliğini belirlemektir.
Yöntemler: Ocak 2019 ile Nisan 2024 tarihleri arasında tüm vücut 18F-FDG PET/BT yapılan, malignite tanısı almış veya şüphesi olan 5.380 hastanın PET/BT raporları retrospektif olarak incelendi. Fokal kolonik 18F-FDG tutulumu gösteren ve ardından kolonoskopiye yönlendirilen hastalar çalışmaya dahil edildi.
Bulgular: Kolonoskopi yapılan 110 hastanın 63’ünde (%57,3) adenom, 14’ünde (%12,7) malign tümör tespit edildi. Maksimum standardize tutulum değeri (SUVmax) üzerinden oluşturulan ROC eğrisi, malign lezyonların malign olmayanlardan ayrılmasında 0.958'lik bir AUC gösterdi. 13,80'lik bir eşik değeri, malign lezyonları ayırt etmek için %92 duyarlılık, %89 özgüllük, %56 pozitif prediktif değer ve %98 negatif prediktif değer sağladı. SUVmax, maligniteyi diğer kolonoskopik bulgulardan anlamlı şekilde ayırt etti (P < .001). Adenomlar ile benign veya fizyolojik bulgular arasında ise anlamlı fark bulunamadı (P > .05).
Sonuç: Kolonoskopi sonuçları, malign lezyonların diğer lezyon türlerine veya fizyolojik tutuluma kıyasla anlamlı derecede yüksek SUVmax değerlerine sahip olduğunu gösterdi. Bununla birlikte, SUVmax değeri, benign lezyonları adenomlardan ayırt etmek için yeterli olmadı. Bu nedenle, rastlantısal kolonik bulguların tümü dikkatlice değerlendirilmelidir ve SUVmax ≥ 13,80 olan lezyonlar için hızla inceleme planlanmalıdır.
Aims: Incidental focal 18-fluorodeoxyglucose (18F-FDG) uptake in the colorectal region on positron emission tomography/computed tomography (PET/CT) may indicate premalignant lesions, such as adenomas or malignancies. Early detection and diagnosis are crucial for cancer prevention. This study aimed to assess the characteristics of incidental focal colonic FDG uptake associated with benign, premalignant, and malignant lesions, and to determine when colonoscopy is necessary.
Methods: A retrospective review of PET/CT reports was conducted on 5.380 patients with confirmed or suspected malignancies who underwent whole-body 18F-FDG PET/CT between January 2019 and April 2024. Patients exhibiting focal colonic 18F-FDG uptake and subsequently referred for colonoscopy were included in this study.
Results: Among 110 patients who underwent colonoscopy, 63 (57.3%) had adenomas and 14 (12.7%) had malignant tumors. The receiver operating characteristic (ROC) curve based on the maximum standardized uptake value (SUVmax) showed an AUC of 0.958. A cutoff value of 13.80 was optimal for distinguishing malignant lesions from nonmalignant lesions, with a sensitivity of 92%, specificity of 89%, positive predictive value of 56%, and negative predictive value of 98%. The SUVmax significantly differentiated malignancy from other colonoscopic findings (p<0.001). No significant differences were observed between adenomas and benign or physiological findings (p>0.05).
Conclusion: The colonoscopy results indicated that malignant lesions had significantly elevated SUVmax values compared to other lesion types or physiological uptake. However, the SUVmax was not sufficient to distinguish benign lesions from adenomas. Therefore, all incidental colonic findings should be thoroughly assessed, and lesions with SUVmax ≥13.80 should be promptly evaluated.
Primary Language | English |
---|---|
Subjects | Gastroenterology and Hepatology |
Journal Section | Original Article |
Authors | |
Publication Date | January 12, 2025 |
Submission Date | November 30, 2024 |
Acceptance Date | December 22, 2024 |
Published in Issue | Year 2025 Volume: 8 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.